TY  - JOUR
AU  - Guilarte, Mar
AU  - Sala-Cunill, Anna
AU  - Luisa Baeza, Maria
AU  - Cabanas, Rosario
AU  - Dolores Hernandez, Maria
AU  - Ibanez, Ethel
AU  - Hernando de Larramendi, Carlos
AU  - Lleonart, Ramon
AU  - Lobera, Teofilo
AU  - Marques, Luis
AU  - de San Pedro, Blanca Saenz
AU  - Botha, Jaco
AU  - Andresen, Irmgard
AU  - Caballero, Teresa
AU  - IOS Study Grp
PY  - 2021
DO  - 10.1186/s13223-021-00641-3
SN  - 1710-1492
UR  - https://hdl.handle.net/10668/26598
T2  - Allergy asthma and clinical immunology
AB  - Background The Icatibant Outcome Survey (IOS) is an international registry monitoring the use of icatibant, a bradykinin B-2 receptor antagonist indicated for the acute treatment of hereditary angioedema (HAE) attacks. Our goal was to assess disease...
LA  - en
PB  - Bmc
KW  - Hereditary angioedema
KW  - Registries
KW  - Spain
KW  - Bradykinin
KW  - Bradykinin B-2 receptor antagonists
KW  - Icatibant
KW  - On-demand treatment
KW  - Attacks
KW  - Management
KW  - Symptoms
TI  - Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain
TY  - research article
VL  - 17
ER  -